Serine peptidase inhibitor Kazal type III (SPINK3) promotes BRL‐3A cell proliferation by targeting the PI3K–AKT signaling pathway
Keyword(s):
Type Iii
◽
Keyword(s):
Keyword(s):
2021 ◽
Vol 11
(9)
◽
pp. 1785-1791
2018 ◽
Vol 120
(5)
◽
pp. 8291-8299
◽